Download
s00066-020-01689-7.pdf 637,08KB
WeightNameValue
1000 Titel
  • Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
1000 Autor/in
  1. Krug, David |
  2. Baumann, René |
  3. Krockenberger, Katja |
  4. Vonthein, Reinhard |
  5. Schreiber, Andreas |
  6. Boicev, Alexander |
  7. Würschmidt, Florian |
  8. Weinstrauch, Evelyn |
  9. Eilf, Kirsten |
  10. Andreas, Peter |
  11. Höller, Ulrike |
  12. Dinges, Stefan |
  13. Piefel, Karen |
  14. Zimmer, Jörg |
  15. Dellas, Kathrin |
  16. Dunst, Jürgen |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-01
1000 Erschienen in
1000 Quellenangabe
  • 197(1):48-55
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00066-020-01689-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801347/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!We report results of a multicenter prospective single-arm phase II trial (ARO-2013-04, NCT01948726) of moderately accelerated hypofractionated radiotherapy with a simultaneous integrated boost (SIB) in patients with breast cancer receiving adjuvant radiotherapy after breast-conserving surgery.!##!Methods!#!The eligibility criteria included unifocal breast cancer with an indication for adjuvant radiotherapy to the whole breast and boost radiotherapy to the tumor bed. The whole breast received a dose of 40 Gy and the tumor bed a total dose of 48 Gy in 16 fractions of 2.5 and 3 Gy, respectively. Radiotherapy could be given either as 3D conformal RT (3D-CRT) or as intensity-modulated radiotherapy (IMRT). The study was designed as a prospective single-arm trial to evaluate the acute toxicity of the treatment regimen. The study hypothesis was that the frequency of acute skin reaction grade ≥2 would be 20% or less.!##!Results!#!From November 2013 through July 2014, 149 patients were recruited from 12 participating centers. Six patients were excluded, leaving 143 patients for analysis. Eighty-four patients (58.7%) were treated with 3D-CRT and 59 (41.3%) with IMRT. Adherence to the treatment protocol was high. The rate of grade ≥2 skin toxicity was 14.7% (95% confidence interval 9.8-21.4%). The most frequent grade 3 toxicity (11%) was hot flashes.!##!Conclusion!#!This study demonstrated low toxicity of and high treatment adherence to hypofractionated adjuvant radiotherapy with SIB in a multicenter prospective trial, although the primary hypothesis was not met.
1000 Sacherschließung
lokal Radiotherapy, Adjuvant/methods [MeSH]
lokal Hot Flashes/chemically induced [MeSH]
lokal Radiotherapy, Conformal/methods [MeSH]
lokal Radiotherapy, Adjuvant/adverse effects [MeSH]
lokal Esthetics [MeSH]
lokal Breast Neoplasms/radiotherapy [MeSH]
lokal Original Article
lokal Adverse events
lokal Intensity modulated radiotherapy
lokal Pain/etiology [MeSH]
lokal Radiation Dose Hypofractionation [MeSH]
lokal Radiotherapy, Conformal/adverse effects [MeSH]
lokal Breast Neoplasms/surgery [MeSH]
lokal Combined Modality Therapy [MeSH]
lokal Radiotherapy, Intensity-Modulated/methods [MeSH]
lokal Acute toxicity
lokal Female [MeSH]
lokal Mastectomy, Segmental [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Breast Neoplasms/drug therapy [MeSH]
lokal Radiotherapy, Intensity-Modulated/adverse effects [MeSH]
lokal Chemotherapy, Adjuvant [MeSH]
lokal Antineoplastic Agents, Hormonal/adverse effects [MeSH]
lokal Radiation dermatitis
lokal Pilot Projects [MeSH]
lokal Antineoplastic Agents, Hormonal/therapeutic use [MeSH]
lokal Treatment compliance
lokal Radiodermatitis/etiology [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-8811-5416|https://frl.publisso.de/adhoc/uri/QmF1bWFubiwgUmVuw6k=|https://frl.publisso.de/adhoc/uri/S3JvY2tlbmJlcmdlciwgS2F0amE=|https://frl.publisso.de/adhoc/uri/Vm9udGhlaW4sIFJlaW5oYXJk|https://frl.publisso.de/adhoc/uri/U2NocmVpYmVyLCBBbmRyZWFz|https://frl.publisso.de/adhoc/uri/Qm9pY2V2LCBBbGV4YW5kZXI=|https://frl.publisso.de/adhoc/uri/V8O8cnNjaG1pZHQsIEZsb3JpYW4=|https://frl.publisso.de/adhoc/uri/V2VpbnN0cmF1Y2gsIEV2ZWx5bg==|https://frl.publisso.de/adhoc/uri/RWlsZiwgS2lyc3Rlbg==|https://frl.publisso.de/adhoc/uri/QW5kcmVhcywgUGV0ZXI=|https://frl.publisso.de/adhoc/uri/SMO2bGxlciwgVWxyaWtl|https://frl.publisso.de/adhoc/uri/RGluZ2VzLCBTdGVmYW4=|https://frl.publisso.de/adhoc/uri/UGllZmVsLCBLYXJlbg==|https://frl.publisso.de/adhoc/uri/WmltbWVyLCBKw7ZyZw==|https://frl.publisso.de/adhoc/uri/RGVsbGFzLCBLYXRocmlu|https://frl.publisso.de/adhoc/uri/RHVuc3QsIErDvHJnZW4=
1000 Hinweis
  • DeepGreen-ID: d17d8154f0d642ba988a5e4debda646c ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6443222.rdf
1000 Erstellt am 2023-04-26T17:46:11.935+0200
1000 Erstellt von 322
1000 beschreibt frl:6443222
1000 Zuletzt bearbeitet 2023-10-19T14:15:41.113+0200
1000 Objekt bearb. Thu Oct 19 14:15:41 CEST 2023
1000 Vgl. frl:6443222
1000 Oai Id
  1. oai:frl.publisso.de:frl:6443222 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source